PRIMARY SURGICAL THERAPY FOR BIOLOGICALLY DEFINED LOW-RISK NEUROBLASTOMA

本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者（PI）可能已经从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。列出的机构是中心的，不一定是研究者的机构。本研究不接受新入组。（来自国家癌症研究所PDQ数据库的临床试验总结）单独手术可能对治疗神经母细胞瘤的儿童有效。这是一项III期试验，旨在研究单纯手术治疗患有神经母细胞瘤的儿童的有效性。患者将接受手术切除肿瘤和受累的淋巴结。一些患者也可能接受联合化疗、进一步手术和/或放射治疗。患者将接受随访评估

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is closed to new enrollment. (Clinical trial summary from the National Cancer Institute's PDQ database) Surgery alone may be effective in treating children with neuroblastoma.This is a Phase III trial to study the effectiveness of surgery alone in treating children who have neuroblastoma. Patients will undergo surgery to remove the tumor and involved lymph nodes. Some patients may also receive combination chemotherapy, further surgery, and/or radiation therapy. Patients will receive follow-up evaluation